Nema internetske veze — prikazuje se spremljena verzija stranice.

Lunai Bioworks In…

USUSD
← Na filtar dionica

Lunai Bioworks Inc. (US:LNAI) — Biotechnology: Pharmaceutical Preparations. Broj burzi na kojima se trguje dionicama tvrtke: 1. Na ovoj stranici — cijena i grafikon, dividende, najveći dioničari i povijest broja dionica.

O tvrtki

Web-stranica
renovarobio.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sjedište
SUITE 906 LOS ANGELES, United States
Upravljanje
David H. Weinstein
Zaposlenici
12
Dionice u optjecaju
5.03 mil. na dan 2026-10-13
DatumDionicePromjena
13.10.20265.03 mil.−86.1%otkup
15.05.202636.27 mil.
Broj dionica prema izvješćima tvrtke. Podjela dionica prepoznaje se po skoku broja za cijeli broj puta.
Slobodno prenosive dionice
4.23 mil.
Tržišna kapitalizacija
829 677 USD
Insajderi
37.48%
Institucionalni ulagači
3.92%
Djelatnost (SIC)
Pharmaceutical Preparations
P/E
gubitak
EPS
−1.06 USD
FCF
−5.29 mil. USD
Dug
388 tis. USD
neto novac
Zarada i FCF — za 12 mjeseci do 30.06.2026 (najnovije izvješće tvrtke).
Neto dobit
−3.56 mil. USD za 12 mj.
Za posljednjih 12 mjeseci do 30.06.2026 (4 kvartala)
Prihodi52.0 tis. USD
− Troškovi8.80 mil. USD
Neto dobit−3.56 mil. USD
Povijest po kvartalima
PrihodiTroškoviGubitak
30.09.2023: Prihodi 61.2 tis. · Troškovi 8.95 mil. · Operativna dobit −8.88 mil. · Neto dobit −9.18 mil.31.12.2023: Prihodi 15.9 tis. · Troškovi 4.29 mil. · Operativna dobit −4.27 mil. · Neto dobit −4.53 mil.31.03.2024: Prihodi 0 · Troškovi 51.4 mil. · Operativna dobit −51.4 mil. · Neto dobit −59.0 mil.30.06.2024: Prihodi 0 · Troškovi 17.1 mil. · Operativna dobit −17.1 mil. · Neto dobit −15.7 mil.30.09.2024: Prihodi 0 · Troškovi 53.3 mil. · Operativna dobit −53.3 mil. · Neto dobit −44.2 mil.31.12.2024: Prihodi 0 · Troškovi 4.55 mil. · Operativna dobit −4.55 mil. · Neto dobit −7.25 mil.31.03.2025: Prihodi 0 · Troškovi 4.16 mil. · Operativna dobit −4.16 mil. · Neto dobit 189 tis.30.06.2025: Prihodi 0 · Troškovi 127 mil. · Operativna dobit −127 mil. · Neto dobit −127 mil.30.09.2025: Prihodi 0 · Troškovi 3.31 mil. · Operativna dobit −3.31 mil. · Neto dobit 2.82 mil.31.12.2025: Prihodi 0 · Troškovi 1.82 mil. · Operativna dobit −1.82 mil. · Neto dobit −1.80 mil.31.03.2026: Prihodi 20.9 tis. · Troškovi 1.50 mil. · Operativna dobit −1.48 mil. · Neto dobit −2.57 mil.30.06.2026: Prihodi 31.1 tis. · Troškovi 2.17 mil. · Operativna dobit −2.14 mil. · Neto dobit −2.01 mil.
09.202306.2026
Zeleno iznad narančastog je dobit (prihodi − rashodi); crveno ispod nule je gubitak.
NAV
−1.96 USD
Datum bilance30.06.2026
Imovina9.94 mil. USD
− Obveze19.0 mil. USD
= NAV (kapital dioničara tvrtke)−9.02 mil. USD
− Goodwill5.96 mil. USD
− Nematerijalna imovina1.41 mil. USD
= Materijalna NAV−16.4 mil. USD
Dionice4 615 503
NAV po dionici−1.96 USD
Opipljivi NAV po dionici−3.55 USD
Kapital je negativan: obveze premašuju imovinu (često zbog otkupa velikih dionica). P/NAV se ne izračunava.
Povijest NAV-a
Datum bilanceNAVNAV po dionici
30.06.2026−9.02 mil. USD−1.96 USD
31.03.2026−9.55 mil. USD−0.27 USD
31.12.2025−13.5 mil. USD−0.56 USD
30.09.2025−13.0 mil. USD−0.56 USD
30.06.2025−21.3 mil. USD−9.63 USD
31.03.202588.4 mil. USD0.54 USD
31.12.202482.1 mil. USD0.51 USD
30.09.202498.1 mil. USD0.61 USD
Opis

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States, Canada, and the Netherlands. It operates through two segments, RENB and BioSymetrics. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops BioSymetrics platform, for multi-omics integration for target identification and validation; clinical trial optimization, including patient stratification and response monitoring; and screening of gene and small molecule effects for the purpose of identifying novel drug targets and therapeutics. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is based in Sacramento, California.

oglas

Burze i oznake

BurzaOznakaValutaCijenaVrsta
US USA StocksLNAIUSD0.2361 -6.50%obične dionice

Cijena

US:LNAI · USD
Prijeđite mišem / dodirnite dan — cijene otvaranja, zatvaranja, najviša i najniža

Najveći imatelji

ImateljUdioDioniceDatum izvješća
VAN TILBURG MAURICE (Dir…≈4.98%250 0002025-01-21
Ground Swell Capital, LL…1.06%53 2112026-06-30
State Street Corporation0.75%37 5372026-06-30
Fidelity Concord Street…0.52%26 4282026-09-30
Geode Capital Management…0.48%24 1562026-06-30
Jane Street Group, LLC0.47%23 6832026-06-30
Vanguard Capital Managem…0.32%16 0812026-06-30
Blackrock Inc.0.32%15 9062026-06-30
Virtu Financial LLC0.26%12 8632026-06-30
VANGUARD INDEX FUNDS-Van…0.24%12 0632026-06-30
Vanguard Fiduciary Trust…0.17%8 6422026-06-30
Fidelity Concord Street…0.15%7 3812026-09-30
Fidelity Concord Street…0.03%1 7542026-08-31
Royal Bank of Canada0.03%1 6872026-06-30
Tower Research Capital L…0.03%1 4052026-06-30
ADVISORS' INNER CIRCLE I…0%232026-07-31